Filings

7 documents · 83 matches

1. CLRB Cellectar Biosciences, Inc. 10-K 2026-03-04

   Item 1A. Risk Factors.

   material weaknesses that are described further in Item 9A. below. These material weaknesses resulted in our historical financial statements requiring
   13 matches in this document Show context Copy citation

2. CLRB Cellectar Biosciences, Inc. 10-Q 2026-11-10

   Item 4. Controls and Procedures

   staff in the Company’s accounting and finance function. This material weakness contributed to additional material weaknesses further described below.
   11 matches in this document Show context Copy citation

3. CLRB Cellectar Biosciences, Inc. 10-Q 2026-08-13

   Item 4. Controls and Procedures

   staff in the Company’s accounting and finance function. This material weakness contributed to additional material weaknesses further described below.
   11 matches in this document Show context Copy citation

4. CLRB Cellectar Biosciences, Inc. 10-Q 2026-05-14

   Item 4. Controls and Procedures

   staff in the Company’s accounting and finance function. This material weakness contributed to additional material weaknesses further described below.
   12 matches in this document Show context Copy citation

5. CLRB Cellectar Biosciences, Inc. 10-Q 2025-11-13

   Item 4. Controls and Procedures

   staff in the Company’s accounting and finance function. This material weakness contributed to additional material weaknesses further described below.
   12 matches in this document Show context Copy citation

6. CLRB Cellectar Biosciences, Inc. 10-Q 2025-08-14

   Item 4. Controls and Procedures

   staff in the Company’s accounting and finance function. This material weakness contributed to additional material weaknesses further described below.
   12 matches in this document Show context Copy citation

7. CLRB Cellectar Biosciences, Inc. 10-Q 2025-05-13

   Item 4. Controls and Procedures

   staff in the Company’s accounting and finance function. This material weakness contributed to additional material weaknesses further described below.
   12 matches in this document Show context Copy citation